Area of research
Reproductive Medicine · Genetics
Research interest
Research interests include Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, Global Cancer Incidence and Screening, and Endometrial and Cervical Cancer Treatments.
Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer
Screening and prevention of ovarian cancer
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality
Risk-prediction models in postmenopausal patients with symptoms of suspected ovarian cancer in the UK (ROCkeTS): a multicentre, prospective diagnostic accuracy study
Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions
Alcohol intake and endogenous sex hormones in women: Meta‐analysis of cohort studies and Mendelian randomization
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction
Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials
Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction
Evolutionary dynamics in the decades preceding acute myeloid leukaemia
Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
Alcohol intake and endogenous sex hormones in women: meta-analysis of cohort studies and Mendelian randomization
Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
Concurrent RB1 loss and <i>BRCA</i> -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Scientific Business Abstracts
Cancer disparities in the context of rurality: risk factors and screening across various U.S. rural classification codes
Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia
Profiling the immune landscape in mucinous ovarian carcinoma
Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews
Randomised trial of population‐based <scp><i>BRCA</i></scp> testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
Reproductive Factors Do Not Influence Survival with Ovarian Cancer
2022cited by 2position: middle
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial